the National Registry of Myocardial Infarction (NRMI3 1999, R13). 13 Worldwide Databases (Table 4) The worldwide databases of acute coronary syndrome were the GRACE (The Global Registry of Acute Coronary Events: R14) 14 and ENACT (European Network for Acute Coronary Treatment: R15) 15 studies.
Analysis of the Databases (Table 5 ) First we analyzed the number of patients, rates of primary PCI and thrombolysis, length of hospital stay and the in-hospital or 30-day mortality rate.
We then investigated the relationship between the PCI volume of the hospitals and their mortality rates in the JSIC and R12 databases. In the American database (R12), the PCI volume was divided into 3 categories: small (low)-volume hospitals (<200 cases per year), intermediatevolume hospitals (200-400 cases per year) and large (high)-volume hospitals (>400 cases per year). Finally, we analyzed the difference in the rate of hospital primary angioplasty volume between Japan and the USA in the JSIC and R16, 16 which included AMI patients enrolled in the registry from 1994 to 1999 in the USA; 446 hospitals with 488,758 patients were eligible for this analysis. In R16, the primary PCI volume of the JSIC hospitals was divided into 3 categories: small (low)-volume primary angioplasty hospitals (<17 cases per year), intermediatevolume primary angioplasty hospitals (17-48 cases per year) and large (high)-volume primary angioplasty hospitals (>48 cases per year).
Statistical Analysis
Chi-square analysis was used to compare dependence of categorical variables. Data were analyzed using JMP Version 5.0 (SAS Campus Drive). A p-value of <0.05 was considered statistically significant.
Results
Japanese Databases (Table 1) R4 is a community study performed by the Miyagi study group from 1998 to 2000 including 1,548 AMI patients in 41 hospitals in Miyagi prefecture. NHAS is the AMI survey by the national hospitals, which was supported by the Japanese Ministry of Health, Labor and Welfare, and included 658 AMI patients registered in 19 hospitals from 1999 to 2000. This survey was not published and reported only in Japanese.
JSIC is a PTCA database in which 50 consecutive PCI patients from 35 hospitals were registered between 1996 and 1999: 12 municipal or prefectural hospitals, 6 corpo- The ratio of primary PCI to AMI patients ranged from 85% to 100% among these centers without significant difference, which indicates that most AMI patients in the JSIC database were treated with primary PCI. The 30-day mortality rate in the low-, intermediate-and large-volume centers was 8.5%, 4.4% and 7.4%, respectively, without a statistically significant difference among them (p=0.10).
As shown in Table 1 , the primary PCI rates ranged from 75% to 94 % in Japan and the in-hospital or 30-day mortality rates were from 5.1% to 10.3%.
European Databases (Table 2)
R6 is the database of the PTCA registry of a German study performed from 1992 to 1994. R7 is the database from a nationwide French Survey performed during November 1995, including 2,152 patients admitted to 312 hospitals for AMI. R8 is the database of the AMI-Florence registry in which 930 cases were enrolled in 6 institutes between March 2000 and February 2001. R9 is the database from the Italian CCU network studied during 2 weeks in October 2001. The primary PCI rate was less than 10% in the databases before 1995 (R6, R7), but has risen to more than 15% recently (R8, R9), and the in-hospital or 30-day mortality rate was 6.6-9.4%. (Table 3) R10 is a meta-analysis done by Heidenreich and McClellan in 1995, R11 is the database from the Cooperative Cardiovascular Project (CCP) for one year, from 1994 to 1995, R12 is the database from the Medicare National Claims History Files for 1977 and R13 is the database from the National Registry of Myocardial Infarction 3 (NRMI 3) in 1999.
American Databases
Worldwide Databases (Table 4) R14 is the database of GRACE study of clinical practice for acute coronary syndrome, which was an observational study performed in 2001 at 94 hospitals in 14 countries (Argentina, Australia, Austria, Belgium, Brazil, Canada, France, Germany, Italy, New Zealand, Poland, Spain, United Kingdom, United States).
R15 is the database of the ENACT registry, which was performed in 1999 at 390 hospitals in 29 European countries.
Outcome of Patients With AMI
The rate of primary PCI was higher in Japan than in the other countries, although recent reports show that it is rising in both Europe and the USA. The rate of thrombolysis for AMI is higher in Europe and the USA than in Japan. The recent studies show that in-hospital or 30-day mortality rates are comparably lower among Japan, Europe, the USA and other countries. Hospital stay is longer in Japan than in the USA (median, 14-23 days vs 4.3 days).
Difference in the Rate of Hospital PCI Volume Between JAPAN and the USA (Fig 1)
These data were derived from the JSIC and R12 databases. The rate in low-volume hospitals is 39% in Japan compared with 26% in the USA, for intermediate-volume hospitals it is 44% in Japan compared with 25% in the USA, and for high-volume hospitals it is only 17% in Japan compared with 49%. The rate in lower-volume hospitals is significantly higher in Japan than in the USA (p<0.0001).
Difference in the Rate of Hospital Primary Angioplasty
Volume Between Japan and the USA (Fig 2) These data were derived from the JSIC PTCA and R16 databases. Although the JSIC does not include the category of low-volume primary angioplasty hospital, the percentage of high-volume primary angioplasty hospital was higher than in the USA with statistical significance (p<0.0001). The primary PCI volume ranged from 20 to 260 cases per year in 35 Japanese hospitals. The ratio of primary PCI per annual PCI caseload was 51% in the lowest-volume centers and 22% in the largest-volume centers, which shows that in Japan the lower the PCI volume per year is, the higher is the primary PCI rate.
Discussion

Hospital PCI and Primary Angioplasty Volumes
Despite documentation of an inverse relationship between PCI volume and the mortality rate of AMI patients, more AMI patients undergo primary PCI in Japan than in Europe, the USA and other countries. The percentage of low-volume hospitals is higher in Japan and because their rates of elective PCI are lower than in higher-volume hospitals, the result is a higher rate of primary PCI in low-volume hospitals in Japan. The mortality rate in lowvolume hospitals is similar to that in high-volume centers in Japan. In Japan, an AMI patient is delivered by ambulance to the nearest hospital equipped with a PCI facility and even if the hospital PCI volume is low, the staff members are supposed to be able to perform this emergency procedure. The lowest primary PCI volume was 20 cases per year in PCI volume hospitals of 90 and 299 cases. Magid et al reported that primary PCI was superior to thrombolytic therapy and reduced in-hospital mortality in centers performing more than 17 primary PCIs per year. 16 In Japan, more than 20 cases per year are treated with primary PCI, even in low-volume hospitals, and all our participating hospitals are intermediate-or high-volume with regard to primary PCI classification.
Increasing Rate of Primary PCI in Europe
The AMI-Florence registry showed that 17.5% of AMI patients were transferred to tertiary hospitals with PCI facilities, which were reported to be higher-volume hospitals, and even after interhospital transportation, the outcomes of those AMI patients treated with primary PCI were good. The recent increase in the rate of primary PCI in Europe is thought to be related to the increasing number of AMI patients who are transferred to tertiary hospitals and this interpretation is supported by the result of PRAGUE-2, 17 a randomized nation multicenter trial done in the Czech Republic in which all patients treated with primary PCI were safely transferred in the acute stage to tertiary PCI centers. The 30-day mortality rate was 6.8%.
Factors Influencing Patient Access to PCI-Equipped Hospitals
Geographical Position It is supposed to be easier for a patient to access PCI-equipped hospitals in Japan than in Europe and the USA from the geographical point of view. Because Japan is a mountainous country, most of the population centers, and thus the hospitals, are concentrated on the plains, which may assist the emergency medical service and contribute to the good prognosis of AMI patients in Japan.
Payment System for In-Hospital Charges In Japan the cost of PCI is fully covered by medical insurance and paid on a fee-for-services (FFS) basis, which includes the doctor's fee, whereas in the USA the hospital charges are paid on a prospective payment system (PPS) basis. Inhospital charges have been compared between the JSIC and PAMI (the Primary Angioplasty in Myocardial Infarction trial) studies. 18 Because the average number of balloons (coronary stents) used per AMI patient was 1.6 (0.7) in Japan and 1.8 (0.8) in USA, the catheter fee was estimated to be more expensive in Japan ($10,000) than in the USA ($2,600). However, the doctor's fee is cheaper in Japan. The total in-hospital charge is greater in Japan ($20,700) than in the USA ($16,000). Kuroda et al also compared the cost of PCI devices in Japan and other countries and reported that the average numbers of balloon and stent used are 1.7±0.8 and 1.0±0.6, respectively. 19 Although they studied elective PCI cases, the numbers of devices was nearly equal to that in R18. The hospital charge for primary PCI is more expensive in Japan than in the USA because of the higher price of devices, not the cost of the room, which is approximately $180 per day in Japan. However, because the Japanese government pays for most of the in-hospital charges in the FFS system, a Japanese patient treated with primary PCI only pays approximately $500, which probably accounts for the higher rate of primary PCI in Japan.
Price of PCI Device According to the reports regarding the cost of PCI devices, 18, [20] [21] [22] [23] the official reimbursement price of a PCI device in Japan consists of an import price, the sales profit of the importer, the margin of the wholesaler and the hospital's margin, which results in the device being nearly 4-fold more expensive than in the USA. Several measures to reduce the price of PCI devices have been proposed. One is to reform the distribution system in Japan; for example, joint purchasing of PCI devices by institutes. Another is the development of local devices made in Japan, which would reduce the cost. Finally, although the prices differential between Japan and other countries should continue to be monitored, we must remember that further advances in PCI technology will have an impact on medical reform and the reduction of medical costs.
Ambulance Service The ambulance service in Japan is also publicly funded and users are transported free of charge to PCI-equipped hospitals.
Hospital Stay There are 2 factors in the longer hospital stay in Japan than in the USA. One is the payment system, as mentioned earlier, and the other is the 1997 Japanese guideline on cardiac rehabilitation for AMI patients with reperfusion therapies, which recommends a hospital admission of 2 or 3 weeks for the AMI patients, a guideline that in the current interventional era might be out of date.
The paradox of the higher in-hospital charge for AMI patients and a higher rate of primary PCI rate has several factors. Because lower-volume hospitals in Japan perform most primary PCI, with a comparable mortality rate to that in other countries, interhospital transportation of AMI patients to tertiary centers is not necessary in Japan. In other words, Japanese AMI patients can be treated with primary PCI in hospital other than large-volume centers.
Study Limitations
The Japanese databases are limited to a regional study (R4: 41 hospitals), a survey by 19 national hospitals (NHAS: not reported in English) and a study by the Society of Interventional Cardiology (JSIC: 35 hospitals) and the data may not reflect the 'real world' of primary PCI in Japan. However, Shihara et al reported a nationwide survey of institutions in Japan, 24 which showed that in 2000 the total number of PCI was 146,992 at 1,240 facilities, with PCI volumes of 85%, 12% and 3%, respectively, at low-, intermediate-and high-volume hospitals. That data suggested that most Japanese hospitals equipped with PCI are low-volume centers, which differs from the result of the JSIC study.
Another limitation is that the JCIS study by Nishigaki et al was a nationwide survey of AMI: 25 66,459 patients with AMI were registered in 2,906 AMI facilities throughout Japan. The data revealed that 80.4% patients with AMI were delivered to 1,211 PCI facilities, but the rate of primary PCI or thrombolysis was not made clear, although most Japanese patients with AMI undergo primary PCI. Further nationwide surveys regarding revascularization therapy for AMI patients are needed in Japan.
With regard to patient access to PCI hospitals, the time from symptom onset to PCI could be analyzed as an indicator of access. According to the Fibrinolysis and Subsequent Transluminal (FAST-3) Trial, 26 the time from onset to emergency room in Japanese AMI patients was approximately 2-3±1-2 h in the center of Tokyo. The equivalent time in the USA not known, although according to R16 approximately 60% of AMI patients arrive at hospitals within 2 h and 30% arrive between 2 and 6 h, which is similar to the Japanese data.
Conclusion
A comparison of Japanese, European, American and other countries' databases regarding primary coronary intervention for AMI suggest that there is a relationship between the primary PCI rate and annual PCI caseload. It is of considerable interest that in Japan even low-volume hospitals have comparable numbers of primary PCI cases.
